EAPC Premium Access

What´s our position? Recent EAPC clinical statements at a glimpse!

Event: ESC Preventive Cardiology 2022
Topic: European Association of Preventive Cardiology (EAPC)
Session type: Symposium
Date: 7 April 2022
Time: 17:05 - 17:50


Become an EAPC member to access this resource

Become a member

Already a member? Sign in

7 presentations in this session

Nutrition and cardiovascular prevention

Speaker: Professor P. Marques-Vidal (Lausanne, CH)

Lifestyle interventions to change obesity-related cardiovascular risk from early childhood to adulthood

Speaker: Doctor H. Hanssen (Basel, CH)

Cardiovascular side effects of doping, ergogenic substances and commonly prescribed medications

Speaker: Doctor P. Adami (Monaco, MC)

Exercise phenotypes of HFpEF patients: an appraisal through diagnosis, pathophysiology and therapy

Speaker: Associate Professor M. Wilhelm (Bern, CH)

Cardiopulmonary assessment prior to returning to high hazard occupations post-symptomatic COVID-19 infection

Speaker: Doctor E. Nicol (London, GB)

How to optimize adherence to pharmacological therapy and lifestyle changes in cardiovascular secondary prevention

Speaker: Professor D. Hansen (Hasselt, BE)

Discussion - What´s our position? Recent EAPC clinical statements at a glimpse!


6 speakers from this session

Professor Pedro Marques-Vidal

Lausanne University Hospital, Lausanne (Switzerland)
14 presentations
0 follower

Doctor Henner Hanssen

University of Basel, Basel (Switzerland)
8 presentations
0 follower

Doctor Paolo Emilio Adami

World Athletics, Monaco (Monaco)
6 presentations
0 follower

Associate Professor Matthias Wilhelm

Bern University Hospital, Inselspital, Bern (Switzerland)
18 presentations
1 follower

Doctor Edward Nicol

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Professor Dominique Hansen

Hasselt University, Hasselt (Belgium)
10 presentations
0 follower

Related content

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk